Themis Medicare Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Themis Medicare.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals	18.4%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You

Dec 27

Themis Medicare (NSE:THEMISMED) Has Announced That It Will Be Increasing Its Dividend To ₹5.00

Aug 28

Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹5.00

Aug 08

Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's

Jul 21

Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's

May 27

Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?

May 12

Calculating The Fair Value Of Themis Medicare Limited (NSE:THEMISMED)

Nov 09

Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?

Oct 26

Increases to Themis Medicare Limited's (NSE:THEMISMED) CEO Compensation Might Cool off for now

Sep 11

Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹4.30

Aug 16

Do Themis Medicare's (NSE:THEMISMED) Earnings Warrant Your Attention?

Jul 09

Estimating The Intrinsic Value Of Themis Medicare Limited (NSE:THEMISMED)

May 14

If You Like EPS Growth Then Check Out Themis Medicare (NSE:THEMISMED) Before It's Too Late

Mar 23

These 4 Measures Indicate That Themis Medicare (NSE:THEMISMED) Is Using Debt Reasonably Well

Mar 02

Why Themis Medicare Limited (NSE:THEMISMED) Is A Top Dividend Stock

Feb 08

Themis Medicare Limited's (NSE:THEMISMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Jan 11

Here's What We Think About Themis Medicare's (NSE:THEMISMED) CEO Pay

Dec 14

Does Themis Medicare (NSE:THEMISMED) Have A Healthy Balance Sheet?

Nov 16

Are You An Income Investor? Don't Miss Out On Themis Medicare Limited (NSE:THEMISMED)

Oct 21

Themis Medicare Limited (NSE:THEMISMED) Looks Interesting, And It's About To Pay A Dividend

Sep 13

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Themis Medicare no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NSEI:THEMISMED - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2023	3,640	453	N/A	N/A	N/A
9/30/2023	3,703	512	-89	179	N/A
6/30/2023	3,565	577	N/A	N/A	N/A
3/31/2023	3,543	569	-127	161	N/A
12/31/2022	3,540	584	N/A	N/A	N/A
9/30/2022	3,602	576	-72	180	N/A
6/30/2022	3,765	591	N/A	N/A	N/A
3/31/2022	3,946	729	138	344	N/A
12/31/2021	3,766	710	N/A	N/A	N/A
9/30/2021	3,472	703	395	570	N/A
6/30/2021	2,947	591	N/A	N/A	N/A
3/31/2021	2,307	357	389	570	N/A
12/31/2020	2,151	349	N/A	N/A	N/A
9/30/2020	2,033	338	131	263	N/A
6/30/2020	1,987	274	N/A	N/A	N/A
3/31/2020	2,016	248	-55	3	N/A
12/31/2019	1,911	61	N/A	N/A	N/A
9/30/2019	1,855	-45	99	124	N/A
6/30/2019	1,846	-64	N/A	N/A	N/A
3/31/2019	1,838	-107	53	109	N/A
12/31/2018	2,002	54	N/A	N/A	N/A
9/30/2018	2,022	78	N/A	N/A	N/A
6/30/2018	2,063	101	N/A	N/A	N/A
3/31/2018	2,095	113	-17	79	N/A
12/31/2017	2,354	105	N/A	N/A	N/A
9/30/2017	2,399	143	N/A	N/A	N/A
6/30/2017	2,323	142	N/A	N/A	N/A
3/31/2017	2,167	160	N/A	-15	N/A
12/31/2016	2,438	211	N/A	N/A	N/A
9/30/2016	2,368	212	N/A	N/A	N/A
6/30/2016	2,404	208	N/A	N/A	N/A
3/31/2016	2,324	163	N/A	258	N/A
12/31/2015	2,287	155	N/A	N/A	N/A
9/30/2015	2,227	142	N/A	N/A	N/A
6/30/2015	2,022	71	N/A	N/A	N/A
3/31/2015	2,019	62	N/A	191	N/A
3/31/2014	1,951	27	N/A	83	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de THEMISMED es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de THEMISMED crezcan más rápidamente que el mercado Indian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de THEMISMED crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de THEMISMED crezcan más rápidamente que el mercado de Indian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de THEMISMED crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de THEMISMED se prevé que sea elevada dentro de 3 años.

Themis Medicare Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Themis Medicare Limited to Report Q4, 2024 Results on May 14, 2024

Investor sentiment improves as stock rises 19%

Third quarter 2024 earnings released: EPS: ₹0.80 (vs ₹1.45 in 3Q 2023)

What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 16%

Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: ₹12.30 (vs ₹1.93 in 2Q 2023)

New minor risk - Market cap size

Investor sentiment deteriorates as stock falls 90%

High number of new directors

Themis Medicare Limited Appoints Reena Patel as Alternate Non-Executive Non- Non-Independent Director to Dr. Adam Demeter, Effective September 11, 2023

Upcoming dividend of ₹5.00 per share at 0.3% yield

Themis Medicare Limited to Report First Half, 2024 Results on Nov 14, 2023

Themis Medicare (NSE:THEMISMED) Has Affirmed Its Dividend Of ₹5.00

First quarter 2024 earnings released: EPS: ₹19.77 (vs ₹18.92 in 1Q 2023)

Themis Medicare Limited to Report Q1, 2024 Results on Aug 10, 2023

Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00

Themis Medicare Limited to Report Q1, 2024 Results on Aug 12, 2023

Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00

We Think Themis Medicare (NSE:THEMISMED) Is Taking Some Risk With Its Debt

Themis Medicare (NSE:THEMISMED) Is Due To Pay A Dividend Of ₹5.00

Full year 2023 earnings released: EPS: ₹61.81 (vs ₹79.22 in FY 2022)

Themis Medicare Limited Recommends Dividend for Financial Year Ended 31 March 2023

Themis Medicare Limited to Report Q4, 2023 Results on May 13, 2023

Themis Medicare Announces DCGI Approval of Remifentanil Hydrochloride 1mg/2mg for Injection for Import and Marketing

Third quarter 2023 earnings released: EPS: ₹14.47 (vs ₹13.54 in 3Q 2022)

Themis Medicare Limited to Report Q3, 2023 Results on Feb 03, 2023

Insider recently sold ₹1.1m worth of stock

Themis Medicare Ltd. Launches Lenzetto Global Brand of Estradiol Novel Drug Delivery System

Themis Medicare Ltd. Launches Lenzetto Global Brand of Estradiol Novel Drug Delivery System

Themis Medicare (NSE:THEMISMED) Seems To Use Debt Quite Sensibly

Investor sentiment improved over the past week

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: ₹19.33 (vs ₹20.95 in 2Q 2022)

Themis Medicare Limited to Report Q2, 2023 Results on Nov 07, 2022

Less than half of directors are independent

Themis Medicare Limited Informs the Second Term of Office of Mr. Hoshang Sinor as Independent Director, Come to End

Investor sentiment improved over the past week

Themis Medicare Limited Announces Resignation of Lajos Kovacs as Board of Directors

Upcoming dividend of ₹5.00 per share

Themis Medicare (NSE:THEMISMED) Has Announced That It Will Be Increasing Its Dividend To ₹5.00

Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹5.00

First quarter 2023 earnings released: EPS: ₹37.84 (vs ₹33.93 in 1Q 2022)

Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's

Themis Medicare Limited to Report Q1, 2023 Results on Jul 28, 2022

Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's

Themis Medicare Limited Recommends Dividend for Financial Year Ended March 31, 2022

Full year 2022 earnings released: EPS: ₹79.22 (vs ₹38.86 in FY 2021)

Themis Medicare Limited, Annual General Meeting, Sep 19, 2022

Themis Medicare Limited Announces Approval for Drug VIRALEX by the Drug Controller General of India

Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?

Now 21% undervalued after recent price drop

Themis Medicare Limited Announces Resignation of Jayshree Dinesh Patel as Whole-Time Director

Themis Medicare Limited Announces Approval of Its Antiviral Drug VIRALEX by the Drug Controller General of India

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Themis Medicare Limited Announces Retirement of Jayshree D Patel, Whole Time Director

Second quarter 2022 earnings released: EPS ₹20.95 (vs ₹8.85 in 2Q 2021)

Calculating The Fair Value Of Themis Medicare Limited (NSE:THEMISMED)

Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?

Independent & Non-Executive Director Humayun Dhanrajgir has left the company

Increases to Themis Medicare Limited's (NSE:THEMISMED) CEO Compensation Might Cool off for now

Upcoming dividend of ₹4.30 per share

First quarter 2022 earnings released: EPS ₹33.93 (vs ₹8.44 in 1Q 2021)

Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹4.30

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Do Themis Medicare's (NSE:THEMISMED) Earnings Warrant Your Attention?

Insider recently sold ₹71k worth of stock

Insider recently sold ₹695k worth of stock

Full year 2021 earnings released: EPS ₹38.86 (vs ₹26.97 in FY 2020)

Themis Medicare Limited Recommends Dividend for the Financial Year Ended March 31, 2021

Investor sentiment improved over the past week